Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,851 signal articles · 236 in last 24h · 135,089 total before filter · latest 1h ago
236last 24h
1096last 7d
174● bullish (7d)
143● bearish (7d)
209publishers
AllMacro305Earnings358M&A77Regulatory26Product11Analyst15
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Amazon Shares Slip as FTC Lawsuit Looms
The Wall Street Journal4d agobearish
Amazon Shares Slip as FTC Lawsuit Looms

Shares of Amazon dropped about 3% in afternoon trading and were recently on pace for their largest percent decrease since July 23, when they fell 4.6%. The Wall Street Journal reported today that the Federal Trade Commission plans to file a lawsuit against the e-commerce giant, alleging it manipulated prices to deceive advertisers into paying higher prices to promote their products.

Amazon stock falls as FTC prepares ad-pricing lawsuit
InvestorsHub4d agobearish
Amazon stock falls as FTC prepares ad-pricing lawsuit

Key takeawaysThe FTC and more than 20 state attorneys general reportedly plan to sue Amazon over its advertising-auction practices. Regulators are expected to allege that undisclosed price floors increased advertisers’ costs and generated tens of billions of dollars for Amazon.

The Energy Sector Stands Out in Today's Selloff
Barrons.com4d agobearish
The Energy Sector Stands Out in Today's Selloff

The energy sector was the only sector solidly in the green on Monday. Brent futures rose above $90 per barrel and WTI futures passed $85 per barrel. The S&P 500 was down 0.5%, while the tech-heavy Nasdaq fell 0.4%.

Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Exec Edge4d agobearish
Cocrystal Pharma: The Strategic Reset Investors May Be Missing

By Mike Sheikh Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of a rescue, but there is more to this story than what meets the eye. Investors glancing at the stock chart may miss the signs of a strategic reset orchestrated by biotech legends, and miss […] The post Cocrystal Pharma: The Strategic Reset Investors May Be Missing appeared first on ExecEdge.

PG&E Falls on Liability Bill; Nvidia Rises on Chip Investment | Stock Movers
Bloomberg4d agobearishVIDEO
PG&E Falls on Liability Bill; Nvidia Rises on Chip Investment | Stock Movers

On this episode of Stock Movers: - PG&E (PGE) are extending their downward move as California legislators introduced a bill that would update the state's wildfire response without shifting liability away from publicly traded utilities. At least three research firms, including BMO Capital Markets and Wells Fargo, downgraded the stock. - Chevron (CVX) and ExxonMobil (XOM) shares are rising along with the price of oil. Washington and Tehran exchanged strikes for the first time in about a month, with US Central Command targeting rocket launchers preparing to send mines into the Strait of Hormuz. In response, the Islamic Revolutionary Guard Corps said that it had attacked US air bases in Jordan. - Nvidia (NVDA) shares are rising after the leader in AI chips dropped 4.6% Friday. It's the only stock rising in the Mag 7 on Monday.

Affirm Drops 4% as Post-Earnings Rally Unwinds Despite 36% GMV Growth
24/7 Wall St.4d agobearish
Affirm Drops 4% as Post-Earnings Rally Unwinds Despite 36% GMV Growth

Affirm just posted one of its strongest quarters in years, yet its stock is sliding twice as fast as the broad market to start the week. The disconnect between the numbers and the price action points to something happening beneath the surface that every investor in the name needs to understand.